Telesis Bio Inc
TBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$78.39K
Close$
$6.67
666690% upside
Current Fair Value
666690% upsideUndervalued by 666690% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $78,394.00 |
|---|---|
| Enterprise Value | $12.65 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | 2.27 |
| Outstanding Shares | 1,732,238 |
Return
| Return on Equity | -1175.81% |
|---|---|
| Return on Assets | -184.14% |
| Return on Invested Capital | -157.00% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.93 |
| Enterprise Value to EBIT | -0.44 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.29 |
| Debt to Equity | 4.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
$-6.39
Average shareholder expectationRevenue Estimate
$2.53 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-6.39
Average shareholder expectationRevenue Estimate
$2.53 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data